1-2 of 2
Karthik Devajaran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Trial Assessing the Feasibility of Romidepsin Combined with Brentuximab Vedotin for Patients Requiring Systemic Therapy for Cutaneous T-Cell Lymphoma

Stefan K. Barta, Tatyana A. Feldman, Jennifer A. DeSimone, Ellen Kim, Karthik Devajaran, Yibin Yang, Henry C. Fung, Tafseer Mahvish, Shazia Nakhoda, Nadia Khan
Journal: Blood
Blood (2022) 140 (Supplement 1): 6543–6544.
https://doi.org/10.1182/blood-2022-157201
Published: 2022
Journal Articles

A Phase I Trial Assessing the Feasibility of Romidepsin Combined with Brentuximab Vedotin for Patients Requiring Systemic Therapy for Cutaneous T-Cell Lymphoma

Stefan K. Barta, MDMRCP,MS, Tatyana A. Feldman, MD, Jennifer A. DeSimone, MD, Ellen Kim, Karthik Devajaran, PhD, David Wiest, PhD, Henry C.H. Fung, MD, Richard I. Fisher, MD, Carlyn Tan, MD, Nadia Khan, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138849
Published: 2020